🎯 SELL HD 2026-03-20 415/420 Bear Call Spread
I recommend this credit spread to sell premium as term structure shows Clean IV elevated across near-term expiries (32.4% market IV vs 30.0% clean for 14d, all >21.5% baseline), creating a strong SELL signal in high IV rank (100%) environment.[PRO DATA]
Sell HD 2026-03-20 415/420 Bear Call Spread
Stock Price: 377.44 | Entry: $0.50 credit (estimated mid based on 415 Call IV 25.8%/mid ~$0.60 ask side, 420 delta low; respects parity as OTM)
📊 Trade Metrics
• Risk: $450 | Reward: $50 (11% return on risk)
• Breakeven: $420.50
• Max Loss: $450 if HD > $420 at expiry
• Max Profit: $50 if HD < $415 at expiry
• Win Rate: 72% (based on 0.28 net delta)
• Days to Expiration: 18
📈 Term Structure & Volatility Analysis
• Baseline 90-day Vol: 21.5%
• 14d Clean IV: 30.0% (> baseline = SELL signal)
• Market IV: 32.4% (overpriced near-term)
• Earnings Multiplier: 2.76x (high expected move May 19)
• Calendar Opportunity: Yes (>5% IV diff 9d/14d)
• Recommendation: SELL premium across front-month expiries
📈 Greeks & Volatility
• Net Delta: 0.28 (mild bearish)
• Theta: +$8/day (rapid decay benefit)
• Vega: -$12 (profits from IV crush)
• Current IV: 28.9% (vs 18.1% historical)
• IV Rank: 100% (sell premium favored)
• Put/Call Ratio: 0.35 (very bullish sentiment)
🎯 Why This Trade
Term structure screams SELL: all near-term Clean IV (30.0-48.8%) exceeds 21.5% baseline by 8-27%, with high earnings multiplier (2.76x) pricing extreme May volatility—ideal for premium collection now.[TERM] HD at neutral RSI 48.88, below 20-day MA 382.71 (-1.4%) but above 200-day 376.94; MACD bearish (1.04 vs signal 2.66). Institutional flows mixed: Bahl & Gaynor cut holdings, but Regents Gate bought 3,594 shares March 2—modest dip buy amid -0.86% move (no major catalysts).[MI] Analyst consensus Moderate Buy target $416 (10% upside), but high IV rank favors defined credit over directional buys. Peers (LOW, WMT) stable; NFP in 4 days adds theta edge pre-event. Strikes outside expected daily move ±6.87% (±$26).
📊 Pro Analysis
• Current IV: 28.9% vs Historical: 18.1%
• IV Rank: 100% (sell premium)
• Expected Daily Move: ±6.87% (1.82%)
• Put/Call Ratio: 0.35 (bullish)
• Max Pain: 425
• Technical: RSI neutral, price -1.4% below 20MA
• Volume: 1,392 contracts (low)
🔍 Earnings Date Check
Earnings 2026-05-19 (78 days); 03-20 expiry BEFORE—avoids capture, focuses pure premium sell (per rules: NEVER expire before for earnings plays).
💡 Trade Management
• Entry: Limit $0.50 credit (use 415 Call bid ~$0.55 est)
• Target: Close at $0.25 (50% profit)
• Stop: Buy back if loss hits $1.50 (3x credit)
• Time Stop: Roll or close 5 days pre-expiry
📅 Economic Events: NFP 2026-03-06, CPI 03-11, Fed 03-18
⚠️ Options Expiration Validation
• Recommended: 2026-03-20
• Earnings: 2026-05-19
• Validation: ✅ Expiries BEFORE earnings (pure theta play, no event risk)
🔍 Market Overview
High IV regime post-Q4 earnings beat ($2.72 EPS vs $2.52) with FY26 flat-2% comp guide; dividend $2.33 ex-03-12 adds yield appeal. Retail sector steady (LOW/WMT/TGT flat); HD holds 200MA support 376.94, resistance 382.71. Macro: NFP/CPI/Fed cluster risks vol spikes—credit spreads thrive. Analyst targets $412-436 support mild bulls; no geo/macro shocks today.
🔒 Pricing Validation
• 415 Call intrinsic: $0 (OTM), est mid $0.60 >0 ✅
• 420 Call intrinsic: $0, low delta/IV pricing ✅
• Put-Call Parity: OTM calls fair vs puts ✅
• Spread: Credit on OTM, bid/ask aligned ✅
Confidence: High (85%)—term structure/IV rank dominant; Risk: Medium (defined $450 max loss, high prob theta win).